Trial · NCT00785577
Participant flow30
How many started, completed or left each group, period by period.
1 to 20 of 30
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Study Period 2: Therapy Phase | STARTED | Placebo | 89 | |
| Study Period 2: Therapy Phase | STARTED | Pregabalin | 45 | |
| Study Period 2: Therapy Phase | STARTED | LY545694 21 mg | 43 | |
| Study Period 2: Therapy Phase | STARTED | LY545694 49 mg | 49 | |
| Study Period 2: Therapy Phase | STARTED | LY545694 105 mg | 47 | |
| Study Period 2: Therapy Phase | COMPLETED | Placebo | 78 | |
| Study Period 2: Therapy Phase | COMPLETED | Pregabalin | 36 | |
| Study Period 2: Therapy Phase | COMPLETED | LY545694 21 mg | 25 | |
| Study Period 2: Therapy Phase | COMPLETED | LY545694 49 mg | 36 | |
| Study Period 2: Therapy Phase | COMPLETED | LY545694 105 mg | 27 | |
| Study Period 2: Therapy Phase | NOT COMPLETED | Placebo | 11 | |
| Study Period 2: Therapy Phase | NOT COMPLETED | Pregabalin | 9 | |
| Study Period 2: Therapy Phase | NOT COMPLETED | LY545694 21 mg | 18 | |
| Study Period 2: Therapy Phase | NOT COMPLETED | LY545694 49 mg | 13 | |
| Study Period 2: Therapy Phase | NOT COMPLETED | LY545694 105 mg | 20 | |
| Study Period 3: 1-Week Washout Phase | STARTED | Placebo | 78 | |
| Study Period 3: 1-Week Washout Phase | STARTED | Pregabalin | 36 | |
| Study Period 3: 1-Week Washout Phase | STARTED | LY545694 21 mg | 25 | |
| Study Period 3: 1-Week Washout Phase | STARTED | LY545694 49 mg | 36 | |
| Study Period 3: 1-Week Washout Phase | STARTED | LY545694 105 mg | 27 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00785577/flow